Abstract
Background: Angiotensin converting enzyme inhibitor (ACEI) therapy at discharge for hospitalized heart failure (HF) patients is considered a key quality of care measure, which has led to implementation of quality improvement efforts to comply with this recommendation. The benefit of this approach however will be limited if ACEIs are not continued in the outpatient setting. In this study we sought to determine the adherence to outpatient ACEI therapy following hospitalization for HF. Methods: Medicare and Medicaid data on 1041 surviving hospitalized HF patients from 1998–2000 were studied to assess ACEI use at discharge and subsequent continued use and new prescription rate of ACEI as outpatients at 30, 180, and 365 days post-discharge among patients who were and were not prescribed ACEI at the time of discharge.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
